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Editors’ NotesMaking Expandable Progenitors
For pluripotent cell-based therapies to become a viable option for clinical use, the problem
of generating sufficient amounts of nontumorigenic pure cell populations for successful
engraftment must be overcome. In this issue, Gadue and colleagues address this challenge
by deriving human endodermal progenitor cell lines from ESCs or iPSCs that can self-
renew almost indefinitely, do not form teratomas when engrafted into mice, and can
differentiate into several endodermal lineages, including functional glucose-responsive
pancreatic b-cells. The Rajagopal and Kotton groups applied a similar overall strategy,
but focused on a more lineage-restricted endodermal population: lung progenitors.
They show that the resulting cells can produce large numbers of pure lung epithelial
cells in culture, and can also engraft in a 3D tissue scaffold (Kotton), form tracheospheres
in mice (Rajagopal) and, when applied to human iPSCs, allow disease modeling of
cystic fibrosis (Rajagopal). In their minireview, Kadzik and Morrisey reflect on these threereports and discuss how lessons from lung endoderm development and differentiation can be used to recapitulate the
differentiation of progenitors in vitro.More Than One Way to skiNSCs a Cat
The recent demonstration that unrelated cells can be reprogrammed
directly to form neurons was an exciting development, but the potential
for application is tempered by the limited expansion capacity of mature
neurons. Reprogramming to form patient-specific self-renewing neural
stem cells instead could potentially circumvent this problem. Here,
the Scho¨ler and Edenhofer groups use different transcription factor combi-
nations to directly reprogram mouse fibroblasts into tripotent induced
neural stem cells (iNSCs) with in vitro and in vivo properties similar to
endogenous NSCs. Although they share a similar endpoint, the iNSCs
developed in these studies were made with different strategies through
seemingly disparate mechanisms and are discussed in a Preview by Zhou
and Tripathi. One of the potential applications of these neural progenitors
could be generation of regionalized functional neurons for cell-based ther-
apies. In an illustration of how in vitro differentiated neurons can be used for
functional benefit, Zhang and colleagues report a strategy for deriving en-
riched populations of striatal GABAergic projection neurons from hESCs,
which project to the substantia nigra and correct motor defects when
engrafted into a mouse model of Huntington’s disease (preview by Parmar
and Bjo¨rklund).
Targeting Cells In Vivo
An alternative to generating cells in culture for regenerative therapies is to target stem cell function in vivo. In her Perspective,
Wagersdiscusseshow thenichecontrols stemcell function in the context of tissuehomeostasis, injury, anddegeneration, thus
making the stemcell niche an attractive venue for directing current and future therapeutic interventions. Sometimes, stemcells
need to be targeted for destruction rather than regeneration, particularly in the case of cancer stem cells. In their paper,
Armstrong and colleagues show how drug-resistant chronicmyeloid leukemia stem cells that evade imantinib (Gleevec) treat-ment can be targeted by either genetic or pharmacological inhibition of b-catenin. In an In Translation
article, Kleppe and Levine point to how targeting drug-resistant leukemia stem cells using this type of
approach could prevent the persistent disease relapse that is currently observed after cessation of
drug treatment. In a similar vein, Shen and Laird preview a recent Cancer Cell report showing how
DNA methyltransferase inhibitors epigenetically reprogram tumor-initiating cells.Regulating Pluripotency
Whether pluripotency factors act as panrepressors of differentiation in hESCs or havemore restricted
roles in preventing specific lineages is not well understood. In this issue, Ivanova and colleagues
assign precise roles for the pluripotency factors Oct4, Nanog, and Sox2/3 in different signaling
contexts, showing that each factor controls particular cell fates. In addition, Surani and colleagues
look at the mechanisms underlying epigenetic conversion of mouse epiblast stem cells to the
more naı¨ve ground state of ESCs. They show that Prdm14 and Klf2 synergistically promote this
conversion and thereby delineate some of the epigenetic changes needed for cellular reprogram-
ming. In doing so, they also provide clues about the mechanisms involved in germ cell specification.Cell Stem Cell 10, April 6, 2012 ª2012 Elsevier Inc. xi
